Where does Tendyne Holdings, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tendyne Holdings, Inc. ranks #4,536 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tendyne Holdings, Inc. hold?

Tendyne Holdings, Inc. holds 78 US utility patents granted between 2016 and 2025, spanning 6 technology areas.

What is Tendyne Holdings, Inc.'s Innovation Score?

Tendyne Holdings, Inc. has an Innovation Score of 40.0 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Tendyne Holdings, Inc.'s patent grant rate increasing or decreasing?

Tendyne Holdings, Inc.'s recent grant velocity is +185% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Tendyne Holdings, Inc.'s patents?

Tendyne Holdings, Inc.'s patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tendyne Holdings, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tendyne Holdings, Inc.

Q: What technology areas does Tendyne Holdings, Inc. focus on?

Tendyne Holdings, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 77 patents, ranking #77 of 3,082 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 78 granted patents across 6 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tendyne ranks #4,536 of 49,997 tracked US assignees by granted-patent volume, with 78 patents across 6 technology areas.

#4,536
of 49,997 US assignees by volume: Top 37%
by Innovation Score (40.0/100): 15.6
avg claims per patent: +185%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4536 · US Corporation #4,536 · 78 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 78 grants
TOP-DECILE #4,536/49,997
PHOTO-FINISH Shenzhen Verdewell…
CPC-NARROW A61F · 6 areas
INNOV-PAR 40.0/100
CLAIMS-RICH 15.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +185% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shenzhen Verdewell Technology Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tendyne’s 40.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.1 pts (38%) Velocity 6.9 pts (17%) Breadth 8.7 pts (22%) Claim depth 9.4 pts (23%)

Qualcomm Incorporated · highest

85
Doheny EYE Institute · near

40
Intellectual… · near

40
Loyola University… · near

40
Medallia · near

40
Tendyne Holdings · this assignee

40
3D Lighting… · lowest

7

What this shows Tendyne's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tendyne?

Each dot is one of Tendyne’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tendyne’s own 15.6 claims/patent is at or below the 18.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Tendyne vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tendyne's grants concentrate

Tendyne Holdings, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 98.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (18 grants) versus a trough of 2 in 2018. By volume, Tendyne sits between Shenzhen Verdewell Technology Limited and Valtech Cardio Ltd..

Tendyne's three-year grant acceleration

From 2019–2021 to 2022–2024, Tendyne Holdings, Inc. moved from 33 to 34 grants (1.03x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Shenzhen Verdewel…

78
Sifive

78
Signal Pharmaceut…

78
Teledyne Instrume…

78
Truecar

78
Universitat Stutt…

78
University of Lou…

78
Valtech Cardio

78
Tendyne Holdings ◀

78

What this shows Tendyne holds 78 patents at rank #4,536, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tendyne

By rank, the assignees closest to #4,536 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Tendyne's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tendyne, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Tendyne ranks #77 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Doheny EYE Institute 40 Medallia, Inc. 40 Intellectual Property Innovation Corporation 40 Loyola University of Chicago 40

Similar claim depth

Nearest assignees by average claims per patent (15.6 here).

thyssenkrupp Elevator Corporation 15.6 avg Korrus, Inc. 15.6 avg Ingersoll-Rand Industrial U.S., Inc. 15.6 avg GE-Hitachi Nuclear Energy Americas LLC 15.6 avg

Tendyne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Tendyne Holdings, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	3.8%
2017	5	6.4%
2018	2	2.6%
2019	10	12.8%
2020	9	11.5%
2021	14	17.9%
2022	18	23.1%
2023	12	15.4%
2024	4	5.1%
2025partial year	1	1.3%

Which technologies does Tendyne Holdings, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 77

A61B - DIAGNOSIS; SURGERY; Identification 52

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 16

C08L - Compositions OF Macromolecular Compounds 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tendyne Holdings, Inc.'s patent record in context - here's where to go next.

Tendyne Holdings, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 98.7% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #4,536 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tendyne Holdings, Inc. against Shenzhen Verdewell Technology Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.